Global Blood Therapeutics, Inc. (GBT), is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. More »

Featured News

Recent News

08/07/19GBT Reports Recent Business Progress and Second Quarter 2019 Financial Results
08/06/19GBT Announces Participation at the 2019 Wedbush PacGrow Healthcare Conference
08/02/19GBT Announces New Employment Inducement Grants
07/10/19GBT and Advocates Launch Disease Awareness Campaign Focused on Breaking Down Stigmas Associated with Sickle Cell Disease

More »

Media Resources

Media Contact

Stephanie Yao